Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron

Cited by (959)

Items 901–959 of 959

  1. Additional file 2 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
    Parra Bravo, Celeste, Karen Krukowski, Barker, Sarah, Chao Wang, Li, Yaqiao, Fan, Li, Edwin Vázquez‐Rosa, Shin, Min-Kyoo, Man Ying Wong, McCullough, Louise D. et al. · 2024 · Figshare
  2. Additional file 2 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  3. Additional file 1 of Sirt1 protects against hippocampal atrophy and its induced cognitive impairment in middle-aged mice
    Zuhao Sun, Zhao, Shuang, Xinjun Suo, Dou, Yan · 2022 · Figshare
  4. Additional file 4 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  5. Additional file 1 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
    Parra Bravo, Celeste, Karen Krukowski, Barker, Sarah, Chao Wang, Li, Yaqiao, Fan, Li, Edwin Vázquez‐Rosa, Shin, Min-Kyoo, Man Ying Wong, McCullough, Louise D. et al. · 2024 · Figshare
  6. Additional file 1 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Keith W. Nehrke · 2020 · Figshare
  7. Additional file 4 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
    Parra Bravo, Celeste, Karen Krukowski, Barker, Sarah, Wang, Chao, Li, Yaqiao, Fan, Li, Edwin Vázquez‐Rosa, Shin, Min-Kyoo, Man Ying Wong, McCullough, Louise D. et al. · 2024 · Figshare
  8. Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases
    Subashchandrabose Chinnathambi, Nagaraj Rangappa · 2025 · Advances in protein chemistry and structural biology
  9. FAM84B facilitates tau propagation via RYR3-mediated exocytosis in response to neuroinflammation
    Gwangho Yoon, Hyeyeon Park, J. E. Park, Min Kyoung Kam, Jung-Hyun Kim, Eun‐Joo Kim, Sung-Hye Park, Hyunyoung Kim, Gail V.W. Johnson, Ji‐Young Choi et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Value of Diet and Nutraceuticals in the Prevention and Treatment of Mixed Alzheimer’s Disease and Vascular Dementia
    Mutaz Sarhan, Christian Wohlfeld, Evan See, James Robert Fadel, E. Angela Murphy, Daping Fan · 2026 · Nutraceuticals
  11. Application of Open-Search Proteomics for Comprehensive and Accurate Profiling of Known Tau PTMs and Characteristic Mass Shifts in Alzheimer’s Disease
    Jisheng Guo, Menghua Dong, Jiankai Feng, Ranran Liu, Xiaodan Wei, Yanxiang Dong · 2026 · Journal of Proteome Research
  12. Inhaled General Anesthetics in Alzheimer’s Disease Progression: Divergent Effects, Underlying Mechanisms, and Future Perspectives
    Luoman Yang, Ge Song, Emily Parker, Luodan Yang · 2026 · Molecular Neurobiology
  13. Étude de l’agrégation des protéines intrinsèquement désordonnées impliquées dans les maladies d’Alzheimer et de Parkinson
    Juan M. Lopez · 2015 · theses.fr (ABES)
  14. Identification et caractérisation des modifications post-traductionnelles de la protéine TAU : implication dans le processus d'agrégation
    Amina Kamah · 2015 · theses.fr (ABES)
  15. Bone marrow-derived mesenchymal stem cells and their exosomes in Alzheimer's disease: Mechanisms and therapeutic potential
    Rui Su, Qing-Yu Yang · 2026 · New cell
  16. Nouvelle méthode en protéomique pour améliorer l'identification et la quantification des protéines acétylées
    Issa Diallo · 2017
  17. Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer
    Laura Auboyer · 2018 · theses.fr (ABES)
  18. Rôle des modifications post-traductionnelles dans le processus d’agrégation de la protéine Tau
    Clément Despres · 2017 · theses.fr (ABES)
  19. Rôle des altérations transcriptionnelles et épigénétiques dans les déficits comportementaux de la maladie de Huntington
    Caroline Lotz · 2019 · theses.fr (ABES)
  20. Rôle de la neuroinflammation et du récepteur microglial TREM2 dans la progression de deux modèles de tauopathie
    Audrey Vautheny · 2019 · theses.fr (ABES)
  21. Study of the Neuron-Astrocyte Relationship in a Rodent Model of Tauopathy
    Anastasie Maté de Gérando · 2019 · theses.fr (ABES)
  22. Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
    Clément Barbereau · 2020 · theses.fr (ABES)
  23. Identification et caractérisation fonctionnelle de nouveaux sites de clivage de la protéine Tau
    Maxime J. Derisbourg · 2015 · theses.fr (ABES)
  24. Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau
    Clément Danis · 2018 · theses.fr (ABES)
  25. Transmission of Alzheimer pathology in murine and primate models : from proteinopathies to neuronal and cognitive impairments
    Suzanne Lam · 2021 · theses.fr (ABES)
  26. Liaison et impact du zinc sur deux protéines associées aux maladies neuro-dégénératives : tau et TDP-43
    Dahbia Yatoui · 2022 · theses.fr (ABES)
  27. Astrocytes dysfunction in tauopathies
    Emma Augustin · 2023 · theses.fr (ABES)
  28. Protein Modifications and Quality Control System: Target for Alzheimer’s Disease Therapy
    Abdullah Md. Sheikh, Shozo Yano, Shatera Tabassum, Jubo Bhuiya, Atsushi Nagai · 2026 · International Journal of Molecular Sciences
  29. Synergetic inhibition of deubiquitinases and acetyltransferases to regulate tau acetylation and aggregation in SH-SY5Y cell line model of Alzheimer’s disease
    Basavaraju K C, Harshitha D K, Poornima Priyadarshini C. G. · 2026 · Methods in enzymology on CD-ROM/Methods in enzymology
  30. The shell of the amyloid fibrils: new insight on fuzzy coat polymorphs and function in proteinopathies
    Yuliang Han, Zhuohao He · 2026 · Molecular Neurodegeneration Advances
  31. Translational perspectives in drug discovery
    Arpita Robel Khamle, Varshini Dayanand Kore, Abhishek Lakhera, Saroj Kumar Panda, M Bhalla, Parth Sarthi Sen Gupta · 2026 · Elsevier eBooks
  32. From protein synthesis to synaptic plasticity: Role of molecular chaperons in memory-dependent protein homeostasis
    Basavaraju K C, Poornima Priyadarshini C. G. · 2026 · Advances in protein chemistry and structural biology
  33. Tau Protein in Alzheimer's Disease
    Maitreyee Mukherjee, Soumen Dhara, Abhishek Jana, Tathagata Roy · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  34. Tau physiology and pathology: impacts on cellular structures and neurodegenerative diseases
    Vali Akbari, Seifollah Bahramikia · 2026 · Inflammopharmacology
  35. Tau-mediated Mechanisms in Alzheimerʼs Disease Pathogenesis
    Tanu Suma Narayanappa, Vaishnavi Ananthanarayana, Subashchandrabose Chinnathambi · 2026 · Molecular Neurobiology
  36. Histone deacetylases in neurodegeneration and neuronal plasticity
    Bhupesh Mehta, Sinjitha Nambiar, Omkar Shirke, Satyarth Pandita, Yogananda Shamamandri Markandeya · 2026 · Methods in enzymology on CD-ROM/Methods in enzymology
  37. Targeting Histone Deacetylase 2 in Alzheimer’s Disease: From Molecular Insights to Epigenetic Therapeutic Opportunities
    Asha Anand, Anam Sania, Sushil Kumar Singh, Nilesh Gajanan Bajad · 2026 · Molecular Neurobiology
  38. Mechanistic insights on HDAC6 ZnF UBP–Tau interaction through biophysical and computational approaches
    Abhishek Ankur Balmik, Shweta Kishor Sonawane, Nalini Vijay Gorantla, Subashchandrabose Chinnathambi · 2026 · Methods in enzymology on CD-ROM/Methods in enzymology
  39. Chemical probes for Alzheimer’s disease targets
    Sheenagh Aiken, Tryfon Zarganes‐Tzitzikas, Paul E. Brennan · 2026 · Essays in Biochemistry
  40. Disease-specific tau polymorphs are associated with unique protein networks across proteinopathies
    Nicha Puangmalai, Nemil N. Bhatt, Nopparat Suthprasertporn, Ernesto G. Miranda-Morales, Nikita Shchankin, Madison Samples, Ahmet E. Balci, Jia Yi Liew, Mauro Montalbano, Yingxin Zhao et al. · 2026 · The EMBO Journal
  41. Modifications of Lysine Residues 294 and 311 Within the Microtubule‐Binding Region Alter Tau Aggregation and Tubulin Binding Equilibria
    Dominik P. Vogl, Mario Migotti, Robert Konrat, Anne C. Conibear, Christian F. W. Becker · 2026 · Angewandte Chemie
  42. Modifications of Lysine Residues 294 and 311 Within the Microtubule‐Binding Region Alter Tau Aggregation and Tubulin Binding Equilibria
    Dominik P. Vogl, Mario Migotti, Robert Konrat, Anne C. Conibear, Christian F. W. Becker · 2026 · Angewandte Chemie International Edition
  43. Therapeutic targeting of tauopathies: From druggable biology to precision intervention
    Chengjia Zhang, Jialiang Ma, Xinruo Wu, Xingyi Wang, Xiaohua Huang, Honghua Zheng, Yingjun Zhao · 2026 · Pharmacological Research
  44. SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential
    Jiabin Duan, Jiaqi Liu, Qingsheng Meng, Jiahao Liu, Sitian Yang, Fang Zhou, Jing Cao · 2026 · The FASEB Journal
  45. Protein damage and repair in aging: Mechanisms, homeostasis and disease
    Alex Lyakhovich, Luigi Ferrucci · 2026 · Ageing Research Reviews
  46. Targeting tau acetylation in Alzheimer's disease: Molecular mechanisms, pathological consequences, and therapeutic opportunities of dietary phytochemicals
    Basavaraju KC, Poornima Priyadarshini C. G. · 2026 · Biochemical and Biophysical Research Communications
  47. Multivalent ubiquitin recognition regulates multiple stages of Tau self-assembly
    Kevin Muwonge, Luis Fernando Durán-Armenta, Tamás Lázár, Attila Mészáros, Alexander N. Volkov, Alvaro M. Navarro, Cristina Marino‐Buslje, María Laura Fernández, Gustavo J. Gutierrez, Nicholas M. Kanaan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Exercise, DNA methylation, and Alzheimer’s disease: Mechanistic links and future directions in intergenerational research
    Gabriel Said, Adelino Sanchez Ramos da Silva, Guilherme da Silva Rodrigues · 2026 · Ageing Research Reviews
  49. Mapping the Landscape of Tau Post-translational Modifications and Kinase-Specific Phosphorylation Signatures by Orthogonal CZE-MS/MS and NanoRPLC-MS/MS
    Reyhane Tabatabaeian Nimavard, Seyed Amirhossein Sadeghi, Jorge A. Colón-Rosado, Yifan Yue, Fei Fang, Hsiao‐Tien Chien Hagar, Min-Hao Kuo, Liangliang Sun · 2026 · Journal of Proteome Research
  50. BindingDB Entry 50033508: After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    BindingDB · 2012 · UC San Diego
  51. BindingDB Entry 7461: Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
    BindingDB · 2016 · UC San Diego
  52. BindingDB Entry 50045373: Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.
    BindingDB · 2016 · UC San Diego
  53. BindingDB Entry 50016393: Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
    BindingDB · 2023 · UC San Diego
  54. BindingDB Entry 50042999: Progress and developments in tau aggregation inhibitors for Alzheimer disease.
    BindingDB · 2014 · UC San Diego
  55. BindingDB Entry 50003067: Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease.
    BindingDB · 2020 · UC San Diego
  56. BindingDB Entry 50021669: Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges.
    BindingDB · 2025 · UC San Diego
  57. Emerging role of histone deacetylases in chromatin remodeling and protein homeostasis in Alzheimer’s disease
    Abhishek Ankur Balmik, Pukar Khanal · 2026 · Advances in pharmacology
  58. Impact of post-translational modifications in Alzheimer’s disease: An overview
    Ch Venkataramaiah · 2026 · Current Proteomics
  59. Modifications of the tau protein and their varied effects on aggregation and function
    Benjamin Combs · 2013 · KU ScholarWorks (The University of Kansas)